GlucoTrack(GCTK)
$0.20+0.01 (+4.21%)
GCTK
GlucoTrack financials statements
$0.20
At close:+0.01 (+4.21%)
Want to see GCTK full AI Analyst Report?
GlucoTrack (GCTK) Ratios
268 Followers
GlucoTrack Ratios
GCTK's free cash flow for Q2 2026 was $-3.62M. For the 2026 fiscal year, GCTK's free cash flow was increased by $0.00 and operating cash flow was $-3.62M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Mar 25 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.61 | 4.52 | 3.22 | 2.35 | 6.91 |
| Quick Ratio | 1.61 | 4.52 | 3.22 | 2.35 | 6.91 |
| Cash Ratio | 1.55 | 4.41 | 2.97 | 2.28 | 6.87 |
| Solvency Ratio | -3.86 | -1.19 | -4.15 | -3.65 | -3.63 |
| Operating Cash Flow Ratio | -3.19 | -9.80 | -4.34 | -3.68 | -4.27 |
| Short-Term Operating Cash Flow Coverage | -544.29 | -2498.00 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | $ 2.66M | $ -13.16M | $ 3.16M | $ 1.17M | $ 5.00M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.00 | 0.05 | 0.04 | 0.08 | 0.04 |
| Debt-to-Equity Ratio | 0.01 | -0.02 | 0.06 | 0.16 | 0.05 |
| Debt-to-Capital Ratio | 0.01 | -0.02 | 0.06 | 0.14 | 0.05 |
| Long-Term Debt-to-Capital Ratio | 0.00 | -0.02 | 0.06 | 0.14 | 0.04 |
| Financial Leverage Ratio | 2.77 | -0.46 | 1.53 | 1.98 | 1.22 |
| Debt Service Coverage Ratio | -690.93 | -34.65 | 0.00 | -1470.67 | 0.00 |
| Interest Coverage Ratio | 0.00 | -23.16 | 0.00 | -1477.33 | 0.00 |
| Debt to Market Cap | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 1.10 | 2.41 | 1.06 | 1.29 | 1.62 |
| Net Debt to EBITDA | 0.38 | 0.24 | 0.61 | 0.48 | 1.48 |
| Profitability Margins | |||||
| Gross Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EBIT Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EBITDA Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Pretax Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Continuous Operations Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Income Per EBT | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| EBT Per EBIT | 120.50% | 155.34% | 99.90% | 100.07% | 100.67% |
| Return on Assets (ROA) | -247.36% | -380.93% | -144.69% | -181.91% | -64.92% |
| Return on Equity (ROE) | -685.57% | 173.82% | -221.99% | -360.57% | -78.89% |
| Return on Capital Employed (ROCE) | -524.96% | -312.37% | -209.37% | -311.02% | -75.07% |
| Return on Invested Capital (ROIC) | -520.21% | -310.30% | -209.37% | -311.02% | -74.75% |
| Return on Tangible Assets | -247.36% | -380.93% | -144.69% | -181.91% | -64.92% |
| Earnings Yield | -557.00% | -13.57% | -2.45% | -0.34% | -0.11% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Payables Turnover | 0.00 | 0.00 | 0.02 | 0.03 | 0.00 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Working Capital Turnover Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.00 | 0.00 | -23556.54 | -10664.35 | 0.00 |
| Days of Sales Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 0.00 | 0.00 | 23556.54 | 10664.35 | 0.00 |
| Operating Cycle | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -508.32 | -33.58 | -35.45 | -24.21 | -24.47 |
| Free Cash Flow Per Share | -511.52 | -33.86 | -35.45 | -24.22 | -24.51 |
| Dividend Paid and CapEx Coverage Ratio | -158.75 | -120.10 | 0.00 | -3729.00 | -753.80 |
| Capital Expenditure Coverage Ratio | -158.75 | -120.10 | 0.00 | -3729.00 | -753.80 |
| Operating Cash Flow Coverage Ratio | -461.82 | -46.78 | -33.46 | -19.12 | -15.08 |
| Operating Cash Flow to Sales Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Free Cash Flow Yield | -440.59% | -7.57% | -2.26% | -0.29% | -0.10% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -0.18 | 7.37 | -40.90 | -293.76 | -947.40 |
| Price-to-Sales (P/S) Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Price-to-Book (P/B) Ratio | 1.23 | -12.81 | 90.79 | 1059.22 | 747.45 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -0.23 | -13.22 | -44.26 | -349.29 | -1020.95 |
| Price-to-Operating Cash Flow Ratio | -0.23 | -13.33 | -44.26 | -349.38 | -1022.31 |
| Price-to-Earnings Growth (PEG) Ratio | 0.00 | -0.03 | -1.22 | -33.04 | -20.07 |
| Enterprise Value Multiple | 0.20 | -7.35 | -40.37 | -294.81 | -976.71 |
| Enterprise Value | -3.87M | 161.12M | 285.97M | 1.30B | 3.85B |
| EV to EBITDA | 0.20 | -7.35 | -40.37 | -294.81 | -976.71 |
| EV to Sales | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EV to Free Cash Flow | 0.25 | -12.79 | -43.61 | -348.72 | -1019.41 |
| EV to Operating Cash Flow | 0.25 | -12.90 | -43.61 | -348.81 | -1020.77 |
| Tangible Book Value Per Share | 94.33 | -34.95 | 17.28 | 7.99 | 33.47 |
| Shareholders’ Equity Per Share | 94.33 | -34.95 | 17.28 | 7.99 | 33.47 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income Per Share | -646.68 | -60.76 | -38.36 | -28.80 | -26.41 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 1.00 | 1.03 | 1.00 | 1.00 | 1.02 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.79 | 0.55 | 0.92 | 0.84 | 0.93 |
Currency in USD

